SK bioscienceLtd Future Growth
Future criteria checks 1/6
SK bioscienceLtd is forecast to grow earnings and revenue by 6.2% and 2.4% per annum respectively. EPS is expected to grow by 6.5% per annum. Return on equity is forecast to be -0.9% in 3 years.
Key information
6.2%
Earnings growth rate
6.5%
EPS growth rate
Biotechs earnings growth | 53.8% |
Revenue growth rate | 2.4% |
Future return on equity | -0.9% |
Analyst coverage | Good |
Last updated | 31 Jul 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 354,474 | 26,577 | -117,323 | 32,500 | 5 |
12/31/2025 | 320,518 | -18,148 | -38,841 | 56,960 | 8 |
12/31/2024 | 237,092 | -38,420 | 105,640 | 183,700 | 8 |
6/30/2024 | 371,479 | 27,435 | 17,716 | 135,175 | N/A |
3/31/2024 | 371,179 | 22,868 | -47,047 | 71,302 | N/A |
12/31/2023 | 369,506 | 22,318 | -20,949 | 29,346 | N/A |
9/30/2023 | 419,202 | 45,890 | -32,868 | 11,613 | N/A |
6/30/2023 | 278,429 | 18,276 | -162,430 | -123,743 | N/A |
3/31/2023 | 390,231 | 80,378 | -107,916 | -47,766 | N/A |
12/31/2022 | 456,726 | 122,452 | -201,448 | -124,958 | N/A |
12/31/2021 | 929,001 | 355,139 | 492,124 | 536,594 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A302440's forecast earnings growth (6.2% per year) is above the savings rate (2.6%).
Earnings vs Market: A302440's earnings (6.2% per year) are forecast to grow slower than the KR market (28.3% per year).
High Growth Earnings: A302440's earnings are forecast to grow, but not significantly.
Revenue vs Market: A302440's revenue (2.4% per year) is forecast to grow slower than the KR market (10.2% per year).
High Growth Revenue: A302440's revenue (2.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A302440 is forecast to be unprofitable in 3 years.